Prostate Specific Antigen (PSA)(1A7), 0.2mg/mL, Clone: [1A7], Mouse, Monoclonal

Artikelnummer: BOT-BNUB0926-100
Artikelname: Prostate Specific Antigen (PSA)(1A7), 0.2mg/mL, Clone: [1A7], Mouse, Monoclonal
Artikelnummer: BOT-BNUB0926-100
Hersteller Artikelnummer: BNUB0926-100
Alternativnummer: BOT-BNUB0926-100-100UL
Hersteller: Biotium
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC
Spezies Reaktivität: Feline, Human
Immunogen: PSA (p30) from human sperm plasma
Alternative Synonym: Antigen, prostate-specific (APS), Gamma-seminoprotein, hK3, Kallikrein related peptidase 3, Kallikrein-3 (KLK3), KLK2A1, P-30 antigen, Semenogelase, Seminin
This antibody recognizes a single protein of 33-34 kDa, identified as the prostate specific antigen (PSA). This MAb is highly specific to PSA and stains prostatic secretory and ductal epithelium in both normal and neoplastic tissues. PSA is a chymotrypsin-like serine protease (kallikrein family) exclusively produced by the prostate epithelium, and abundant in seminal fluid. PSA can be detected in the sera of patients with prostatic carcinoma. It is predominantly complexed to a liver-derived serine protease inhibitor, alpha-1-antichymotrypsin (ACT). A higher proportion of serum PSA is complexed to ACT in prostate cancer than in benign prostate hyperplasia. This MAb makes an excellent pair with MAb A67-B/E3 for PSA tests.
Klonalität: Monoclonal
Konzentration: 0.2 mg/mL
Klon-Bezeichnung: [1A7]
Molekulargewicht: 33-34 kDa
UniProt: P07288
Puffer: PBS, 0.05% BSA, 0.05% azide
Quelle: Animal
Anwendungsbeschreibung: Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody|Immunohistochemistry (formalin-fixed): 0.5-1.0 ug/mL for 30 minutes at RT|Flow cytometry: 0.5-1 ug/million cells|Immunofluorescence: 0.5-1 ug/mL|Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 minutes followed by cooling at RT for 20 minutes|Optimal dilution for a specific application should be determined by user